Answer:
Based on the excerpt you provided from Immunomeâs Q2â2025 earnings release (published onâŻAugustâŻ6âŻ2025), the specific figures for the companyâs actual earnings (net profit or loss) and revenue as well as the consensus analyst estimates for those metrics are not included in the text you supplied. The only information available in the excerpt is a general statement that Immunome âmade substantial progress ⊠toward key milestones,â but no numerical data on earnings, revenue, or analyst expectations are given.
What this means for your question:
| Metric | Actual result (Q2âŻ2025) | Consensus estimate (Q2âŻ2025) |
|---|---|---|
| Earnings (net profit/loss) | Not provided in the excerpt | Not provided in the excerpt |
| Revenue | Not provided in the excerpt | Not provided in the excerpt |
Next steps to obtain the numbers:
Read the full press release â The complete Business Wire release (or the companyâs Investor Relations page) will contain a detailed financial table that lists:
- Net income (or loss) for the quarter.
- Total revenue (or revenue guidance) for the quarter.
- The analyst consensus estimates for both earnings and revenue, typically highlighted in the âFinancial Highlightsâ or âManagement Discussionâ sections.
Check financial news platforms â Services like Bloomberg, Reuters, or FactSet often publish a âConsensus Estimate vs. Actualâ table shortly after the filing. Look for the âEarnings vs. Estimatesâ section for IMNM (Immunome).
Consult earnings preview/analysis reports â Analysts from firms such as Wedbush, Jefferies, or BofA usually publish brief summaries that include both the actual results and a comparison to consensus estimates.
Until the full release or a reliable summary that includes the numbers is available, we cannot provide the specific earnings and revenue figures nor the consensus estimates for Immunomeâs Q2â2025 performance. If you can share the detailed portion of the release that contains the numbers, Iâll gladly extract and compare the figures for you.